• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分离株对所选抗菌药物的体外敏感性

In Vitro Susceptibility of Isolates to Selected Antimicrobials.

作者信息

Owusu Enid, Newman Mercy J, Addo Kwesi K, Addo Phyllis

机构信息

Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, University of Ghana, Accra, Ghana.

Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Accra, Ghana.

出版信息

Can J Infect Dis Med Microbiol. 2017;2017:5180984. doi: 10.1155/2017/5180984. Epub 2017 Mar 14.

DOI:10.1155/2017/5180984
PMID:28392809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5368360/
Abstract

The current definitive treatment of Buruli ulcer with antibiotics makes the issue of antimicrobial drug resistance an unavoidable one. This is as a result of drug misuse by health personnel and patients' noncompliance to treatment regimen. Monitoring of these factors and screening for new effective antimicrobials are crucial to effective management of Buruli ulcer disease. This study therefore investigated the inhibitory activity of some antibiotics against isolates of . Activity of eight antibiotics was tested against twelve isolates (2 reference strains and 10 clinical isolates). The anti- activities were determined by the agar dilution method and the minimum inhibitory concentrations (MICs) were determined by the agar proportion method. All antimicrobials investigated had activity against isolates tested. The MICs ranged from 0.16 g/mL to 2.5 g/mL. Azithromycin recorded the highest inhibitory activity at a mean MIC of 0.39 g/mL, whilst clofazimine a second-line antileprosy drug, recorded the lowest at a mean MIC of 2.19 g/mL. Among the four antituberculosis drugs, rifampicin had the highest activity with a mean MIC of 0.81 g/mL. Azithromycin could be considered as a lucrative alternative to existing treatment methods for inhibiting in Ghana.

摘要

目前用抗生素对布鲁里溃疡进行的确定性治疗使得抗菌药物耐药性问题不可避免。这是卫生人员药物使用不当以及患者不遵守治疗方案所致。监测这些因素并筛选新的有效抗菌药物对于有效管理布鲁里溃疡病至关重要。因此,本研究调查了某些抗生素对……分离株的抑制活性。针对12株……分离株(2株参考菌株和10株临床分离株)测试了8种抗生素的活性。通过琼脂稀释法测定抗菌活性,通过琼脂比例法测定最低抑菌浓度(MIC)。所有研究的抗菌药物对所测试的……分离株均有活性。MIC范围为0.16μg/mL至2.5μg/mL。阿奇霉素的抑制活性最高,平均MIC为0.39μg/mL,而二线抗麻风病药物氯法齐明的抑制活性最低,平均MIC为2.19μg/mL。在四种抗结核药物中,利福平的活性最高,平均MIC为0.81μg/mL。在加纳,阿奇霉素可被视为抑制……的现有治疗方法的一种有利替代方案。

相似文献

1
In Vitro Susceptibility of Isolates to Selected Antimicrobials.分离株对所选抗菌药物的体外敏感性
Can J Infect Dis Med Microbiol. 2017;2017:5180984. doi: 10.1155/2017/5180984. Epub 2017 Mar 14.
2
Susceptibility Profiles of Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of Ghana.加纳东部地区两个区分离株对链霉素和利福平的药敏谱
Int J Microbiol. 2016;2016:8304524. doi: 10.1155/2016/8304524. Epub 2016 Dec 14.
3
Comparison of E-test with agar dilution methods in testing susceptibility of N. gonorrhoeae to azithromycin.E试验与琼脂稀释法检测淋病奈瑟菌对阿奇霉素敏感性的比较。
Sex Transm Dis. 1997 May;24(5):257-60. doi: 10.1097/00007435-199705000-00004.
4
In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.土耳其分离的布鲁氏菌对各种抗菌药物的体外活性。
Infect Dis (Lond). 2015 Jun;47(6):364-9. doi: 10.3109/00365548.2014.988748. Epub 2015 Feb 24.
5
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.缩短布鲁里溃疡治疗时间的联合疗法:靶向呼吸链并利用溃疡分枝杆菌基因衰减。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00426-19. Print 2019 Jul.
6
In Vitro Assessment of Drug Activity Against Mycobacterium ulcerans.体外评估抗溃疡分枝杆菌药物活性。
Methods Mol Biol. 2022;2387:189-194. doi: 10.1007/978-1-0716-1779-3_18.
7
Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against .将他汀类药物重新用于治疗布鲁里溃疡:针对……的抗菌活性
Front Microbiol. 2023 Sep 29;14:1266261. doi: 10.3389/fmicb.2023.1266261. eCollection 2023.
8
In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans.环丙沙星、司帕沙星、氧氟沙星、阿米卡星和利福平对加纳溃疡分枝杆菌分离株的体外活性。
J Antimicrob Chemother. 2000 Feb;45(2):231-3. doi: 10.1093/jac/45.2.231.
9
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
10
In vitro susceptibility of Mycobacterium ulcerans to clarithromycin.溃疡分枝杆菌对克拉霉素的体外敏感性
Antimicrob Agents Chemother. 1998 Aug;42(8):2070-3. doi: 10.1128/AAC.42.8.2070.

引用本文的文献

1
Management of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: consensus statement.澳大利亚溃疡分枝杆菌感染(布鲁里溃疡)的管理:共识声明
Med J Aust. 2025 Jun 16;222(11):571-578. doi: 10.5694/mja2.52591. Epub 2025 Feb 23.
2
Prevalence of yaws and syphilis in the Ashanti region of Ghana and occurrence of H. ducreyi, herpes simplex virus 1 and herpes simplex virus 2 in skin lesions associated with treponematoses.加纳阿散蒂地区雅司病和梅毒的流行情况以及与密螺旋体病相关的皮肤损伤中杜克雷嗜血杆菌、单纯疱疹病毒 1 和单纯疱疹病毒 2 的发生情况。
PLoS One. 2024 May 22;19(5):e0295088. doi: 10.1371/journal.pone.0295088. eCollection 2024.
3
Mycobacterium ulcerans challenge strain selection for a Buruli ulcer controlled human infection model.溃疡分枝杆菌挑战株的选择用于控制人类感染的伯氏疏螺旋体溃疡模型。
PLoS Negl Trop Dis. 2024 May 3;18(5):e0011979. doi: 10.1371/journal.pntd.0011979. eCollection 2024 May.
4
Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans.阿莫西林/克拉维酸联合利福平/克拉霉素对溃疡分枝杆菌具有杀菌作用。
PLoS Negl Trop Dis. 2024 Apr 4;18(4):e0011867. doi: 10.1371/journal.pntd.0011867. eCollection 2024 Apr.
5
Pharmacologic management of infection.感染的药物治疗管理。
Expert Rev Clin Pharmacol. 2020 Apr;13(4):391-401. doi: 10.1080/17512433.2020.1752663. Epub 2020 Apr 20.

本文引用的文献

1
Primary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens.初次培养:临床标本周转时间长对污染及溃疡分枝杆菌生长的影响因素
BMC Infect Dis. 2014 Nov 30;14:636. doi: 10.1186/s12879-014-0636-7.
2
Health-related quality of life among persons living with buruli ulcer in amasaman community, ga west district accra, ghana.加纳阿克拉西区加西部阿玛萨曼社区布鲁里溃疡患者的健康相关生活质量
Int J Health Sci (Qassim). 2011 Jan;5(1):29-38.
3
Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?治疗溃疡分枝杆菌病(俗称“非洲溃疡”):从手术到抗生素,药丸是否比刀更有效?
Future Microbiol. 2011 Oct;6(10):1185-98. doi: 10.2217/fmb.11.101.
4
Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection).麻风病和布鲁里溃疡(溃疡分枝杆菌感染)的最新进展。
Curr Opin Infect Dis. 2010 Oct;23(5):445-55. doi: 10.1097/QCO.0b013e32833c2209.
5
Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).链霉素-利福平联合用药治疗布鲁里溃疡(溃疡分枝杆菌病)具有良好的临床疗效。
Antimicrob Agents Chemother. 2007 Nov;51(11):4029-35. doi: 10.1128/AAC.00175-07. Epub 2007 May 25.
6
Mycobacterium ulcerans infection: control, diagnosis, and treatment.溃疡分枝杆菌感染:控制、诊断与治疗
Lancet Infect Dis. 2006 May;6(5):288-96. doi: 10.1016/S1473-3099(06)70464-9.
7
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.利福平-链霉素联合用药预防人类布氏溃疡早期病变中溃疡分枝杆菌生长的疗效。
Antimicrob Agents Chemother. 2005 Aug;49(8):3182-6. doi: 10.1128/AAC.49.8.3182-3186.2005.
8
Assessing water-related risk factors for Buruli ulcer: a case-control study in Ghana.评估布鲁里溃疡与水相关的风险因素:加纳的一项病例对照研究。
Am J Trop Med Hyg. 2004 Oct;71(4):387-92.
9
[Ecology and transmission of Mycobacterium ulcerans].[溃疡分枝杆菌的生态学与传播]
Pathol Biol (Paris). 2003 Oct;51(8-9):490-5. doi: 10.1016/s0369-8114(03)00151-2.
10
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.利福平-阿米卡星对小鼠溃疡分枝杆菌的杀菌活性。
Antimicrob Agents Chemother. 2002 Oct;46(10):3193-6. doi: 10.1128/AAC.46.10.3193-3196.2002.